Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Preventive health services can save lives at little or no cost

Preventive health services such as daily aspirin use, tobacco cessation screening and alcohol abuse screening can potentially save 2 million lives and nearly $4 billion annually, according to a new paper produced by the National Commission on Prevention Priorities (NCPP). The NCPP is convened by the Partnership for Prevention. Four of the five lead authors perform research with HealthPartners Research Foundation.

8 Sep 2010

Jennerex, Transgene enter partnership to develop JX-594 product for tumor treatment

Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic products for cancer, and Transgene Euronext, a bio-pharmaceutical company specialized in the development of immunotherapeutic products, today announced that they have entered into an exclusive partnership to develop and commercialize JX-594 for the treatment of solid tumors in Europe, the Commonwealth of Independent States (CIS) and the Middle East.

8 Sep 2010

GW Cancer Institute receives grant to establish City-wide Patient Navigation Network in Washington

The GW Cancer Institute (GWCI) was recently awarded a $2.4 million grant from the D.C. Cancer Consortium to establish and coordinate a City-wide Patient Navigation Network (CPNN) in Washington, D.C.

8 Sep 2010

Rexahn Pharmaceuticals publishes research article on RX-8243 anti-tumor activity

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced the publication of a research article in Bioorganic & Medicinal Chemistry Letters on the anti-tumor activity of RX-8243 and its analogues.

3 Sep 2010

Asuragen launches KRAS, BRAF mutational testing in CLIA laboratory

Asuragen, Inc., a leader in molecular diagnostics and nucleic acid-based pharmacogenomics services, announced today that it has launched KRAS and BRAF mutational testing services in its CAP-accredited CLIA laboratory.

2 Sep 2010

Celator Pharmaceuticals raises $20 million in Series D private equity financing

Celator Pharmaceuticals, a privately held pharmaceutical company developing new and more effective therapies to treat cancer based on the company's proprietary technology, today announced that it raised $20 million in a Series D private equity financing.

2 Sep 2010

Abbott RealTime HBV assay receives marketing approval from FDA

Abbott announced today it has received approval from the U.S. Food and Drug Administration to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus in a patient's blood. It is the first and only approved test capable of automating HBV viral load testing from sample extraction to final results.

2 Sep 2010

Eight signs of cancer: Study

Scientists have now identified eight signs of cancer that need immediate attention. These can predict the risk of cancer with such accuracy in certain age groups that patients should be referred to a specialist straight away unless there is a good explanation that is is something else.

30 Aug 2010

NICE draft guidance rejects cancer drug bevacizumab

The National Institute for Health and Clinical Excellence (NICE) has released draft guidance for cancer drug bevacizumab (Avastin).

25 Aug 2010

First patient treated in Synta Pharmaceuticals' clinical trial of STA-9090

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the first patient has been treated in its clinical trial of STA-9090 in combination with docetaxel for the treatment of advanced solid tumor malignancies.

24 Aug 2010

CRC imaging technique identifies early extracolonic lesions of colorectal cancer

Although the medical community has already accepted that colorectal cancer (CRC) screening is cost effective and saves lives, researchers have found that computed tomography colonography (CTC or virtual colonoscopy) not only identifies CRC but also doubles the yield of identifying significant early extracolonic (outside the colon) lesions, resulting in lives saved.

21 Aug 2010

New coverage for colorectal cancer screening to drive US markets for gastrointestinal endoscopy devices in 2010

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, new coverage instituted under the Patient Protection and Affordable Care Act of 2010 will remove the financial disincentives associated with colorectal cancer screening for a large segment of the US population. As a result of these changes in reimbursement, a growing number of colorectal cancer screening procedures will be performed through 2014, driving sales of many gastrointestinal endoscopy devices, including videoscopes and biopsy forceps.

20 Aug 2010

Trial shows positive results for radioembolisation technique for colorectal cancer liver metastases treatment

Using the innovative technique of radioembolisation to treat patients with inoperable colorectal cancer liver metastases who have failed all standard-of-care chemotherapy options can more than double the time until their disease progresses, according to the final results of a Phase III randomised controlled trial published in the prestigious Journal of Clinical Oncology.

20 Aug 2010

SIR-Spheres safe, effective for patients with colorectal cancer liver metastases who have failed chemotherapy

Radioactive yttrium-90 labelled resin microspheres (SIR-Spheres; Sirtex Medical, Sydney, Australia) appear to be a safe and effective treatment for patients with colorectal cancer liver metastases who have failed available chemotherapy options, according to the final results of a prospective clinical multi-centre phase II trial conducted by the Italian Society of Locoregional Therapies in Oncology (SITILO) and published in the British Journal of Cancer.

20 Aug 2010

Study reports uneven decline of colorectal cancer mortality rate

Black patients die from colorectal cancer at much higher rates than whites do and new research points to unequal health care as the cause. While deaths from colorectal cancer have declined over the past 40 years, the declines have been uneven, said lead author Samir Soneji, Ph.D., of the Robert Wood Johnson Health and Society Scholars Program at the University of Pennsylvania.

20 Aug 2010

Immunomedics, GE Healthcare collaborate to evaluate peptide labeling technologies

Immunomedics, Inc. and GE Healthcare, a business unit of General Electric Company, announced today that they have entered into a license and collaboration agreement for the evaluation of labeling technologies based on Immunomedics' patented F-18 peptide labeling method. Terms of the agreement were not disclosed, but GE Healthcare will fund all costs related to this collaboration.

18 Aug 2010

Stand Up To Cancer prepares for next Team Fundraising Challenge

As part of a new long-term alliance, Stand Up To Cancer is gearing up for its next Team Fundraising Challenge by joining forces with one of television's most popular shows, Survivor on CBS. For the first time ever, Survivor will stand up and issue the "Challenge The Odds" Team Challenge with Stand Up To Cancer Ambassador and winner of Survivor: Africa, Ethan Zohn.

18 Aug 2010

USPTO grants Neogenix Oncology patent for DNAs encoding novel molecular aspects of NPC-1 antibody

Neogenix Oncology, Inc. announced today that the U.S. Patent and Trademark Office (USPTO) has issued Patent No. 7,763,720, with claims related to DNAs encoding the novel molecular aspects of the Company's NPC-1 antibody.

18 Aug 2010

Cancer is the world's top 'economic killer,' report finds

The Associated Press: "Cancer is the world's top 'economic killer' as well as its likely leading cause of death, the American Cancer Society contends in a new report it will present at a global cancer conference in China this week. Cancer costs more in productivity and lost life than AIDS, malaria, the flu and other diseases that spread person-to-person, the report concludes.

18 Aug 2010

Cancer Institute of New Jersey expands 'Quality and Outcomes in Cancer Care Research Program'

Looking to gain further understanding about the impact of cancer on patients and families, The Cancer Institute of New Jersey (CINJ) is expanding its Quality and Outcomes in Cancer Care (QOCC) Research Program by welcoming nationally-recognized population science researcher Sharon Manne, PhD. Dr. Manne, who is the recipient of major grant awards from the National Institutes of Health (NIH) for her work in behavioral science, was most recently at the Fox Chase Cancer Center in Philadelphia. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

17 Aug 2010

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Preventive health services can save lives at little or no cost

Jennerex, Transgene enter partnership to develop JX-594 product for tumor treatment

GW Cancer Institute receives grant to establish City-wide Patient Navigation Network in Washington

Rexahn Pharmaceuticals publishes research article on RX-8243 anti-tumor activity

Asuragen launches KRAS, BRAF mutational testing in CLIA laboratory

Celator Pharmaceuticals raises $20 million in Series D private equity financing

Abbott RealTime HBV assay receives marketing approval from FDA

Eight signs of cancer: Study

NICE draft guidance rejects cancer drug bevacizumab

First patient treated in Synta Pharmaceuticals' clinical trial of STA-9090

CRC imaging technique identifies early extracolonic lesions of colorectal cancer

New coverage for colorectal cancer screening to drive US markets for gastrointestinal endoscopy devices in 2010

Trial shows positive results for radioembolisation technique for colorectal cancer liver metastases treatment

SIR-Spheres safe, effective for patients with colorectal cancer liver metastases who have failed chemotherapy

Study reports uneven decline of colorectal cancer mortality rate

Immunomedics, GE Healthcare collaborate to evaluate peptide labeling technologies

Stand Up To Cancer prepares for next Team Fundraising Challenge

USPTO grants Neogenix Oncology patent for DNAs encoding novel molecular aspects of NPC-1 antibody

Cancer is the world's top 'economic killer,' report finds

Cancer Institute of New Jersey expands 'Quality and Outcomes in Cancer Care Research Program'

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Newsletters you may be interested in